xml:space="preserve">
xml:space="preserve">
Advertisement
Advertisement

Looking out for those who have lost a limb | READER COMMENTARY

Dana Burke, a Pennsylvania woman who was shot in the arm in 2004, smiles before beginning another day of testing of a thought-controlled prosthetic arm. Mike Powell, a graduate student at Johns Hopkins is sitting next to her in this 2018 file photograph. (Kim Hairston/Baltimore Sun).
Dana Burke, a Pennsylvania woman who was shot in the arm in 2004, smiles before beginning another day of testing of a thought-controlled prosthetic arm. Mike Powell, a graduate student at Johns Hopkins is sitting next to her in this 2018 file photograph. (Kim Hairston/Baltimore Sun). (Kim Hairston, The Baltimore Sun)

Over 2 million Americans live with limb loss or limb difference, but two-thirds won’t receive a prosthetic device. There is not much information to explain why or if people are getting access to the care they need. That’s why I’m urging Sen. Ben Cardin, Sen. Chris Van Hollen Jr. and Rep. C.A. Dutch Ruppersberger to cosponsor the Triple A Study Act.

The Triple A Study Act solves this problem by identifying the best care practices for people with living with limb loss and limb difference. It studies specific challenges, including how often people are denied coverage for devices and outcomes like whether patients can return to work. Medicare, the VA system, and private insurers will all benefit from this information.

Advertisement

As a member of the limb loss and limb difference community, my experience obtaining a prosthetic device was difficult, and I want other people living with limb loss to have better opportunities so they can live the life they want to live. The Triple A Study Act is important because it will improve the health of millions of people living with limb loss or limb difference.

Robert Raymond, Owings Mills

Advertisement
Advertisement

Add your voice: Respond to this piece or other Sun content by submitting your own letter.

Recommended on Baltimore Sun

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement